Kerry Holford

Stock Analyst at Berenberg

(2.15)
# 2,926
Out of 5,044 analysts
10
Total ratings
42.86%
Success rate
11.56%
Average return
Main Sectors:

Stocks Rated by Kerry Holford

Novo Nordisk
Sep 17, 2025
Upgrades: Buy
Price Target: n/a
Current: $52.14
Upside: -
Eli Lilly and Company
Sep 17, 2025
Downgrades: Hold
Price Target: $970$830
Current: $827.67
Upside: +0.28%